Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 6946 AL 6960

Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment

Zhang S, Han D, Tan X, Feng J, Guo Y, Ding Y.

Int J Clin Pract. 2012 Feb;66(2):185-98. doi: 10.1111/j.1742-1241.2011.02845.x.

Hormesis and amyloid-β protein: physiology or pathology?

Morley JE, Farr SA.

J Alzheimers Dis. 2012;29(3):487-92. doi: 10.3233/JAD-2011-111928.

On the parallel deterioration of lexico-semantic processes in the bilinguals' two languages: evidence from Alzheimer's disease

Costa A, Calabria M, Marne P, Hernández M, Juncadella M, Gascón-Bayarri J, Lleó A, Ortiz-Gil J, Ugas L, Blesa R, Reñé R.

Neuropsychologia. 2012 Apr;50(5):740-53. doi: 10.1016/j.neuropsychologia.2012.01.008. Epub 2012 Jan 13.

Comparison between the story recall test and the word-list learning test in Korean patients with mild cognitive impairment and early stage of Alzheimer's disease

Baek MJ, Kim HJ, Kim S.

J Clin Exp Neuropsychol. 2012;34(4):396-404. doi: 10.1080/13803395.2011.645020. Epub 2012 Jan 23.

A new frontier in spaced retrieval memory training for persons with Alzheimer's disease

Small JA.

Neuropsychol Rehabil. 2012;22(3):329-61. doi: 10.1080/09602011.2011.640468. Epub 2012 Jan 24.

Reducing the risk for Alzheimer's

Thomas SP.

Issues Ment Health Nurs. 2012 Feb;33(2):65. doi: 10.3109/01612840.2012.646211.

Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman

Khan BK, Woolley JD, Chao S, See T, Karydas AM, Miller BL, Rankin KP.

Psychosomatics. 2012 May-Jun;53(3):280-4. doi: 10.1016/j.psym.2011.04.005. Epub 2012 Jan 28.

Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation

Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E, Santos MS, Oliveira CR, Moreira PI.

Brain Res. 2012 Mar 2;1441:64-78. doi: 10.1016/j.brainres.2011.12.063. Epub 2012 Jan 12.

Association between α1-antichymotrypsin signal peptide -15A/T polymorphism and the risk of Alzheimer's disease: a meta-analysis

Guan F, Gu J, Hu F, Zhu Y, Wang W.

Mol Biol Rep. 2012 Jun;39(6):6661-9. doi: 10.1007/s11033-012-1472-8.

Semantic memory and language dysfunction in early Alzheimer's disease: a review

Verma M, Howard RJ.

Int J Geriatr Psychiatry. 2012 Dec;27(12):1209-17. doi: 10.1002/gps.3766. Epub 2012 Feb 1.

Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model

Maloney B, Sambamurti K, Zawia N, Lahiri DK.

Curr Alzheimer Res. 2012 Jun;9(5):589-99. doi: 10.2174/156720512800617955.

Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study

Goveas JS, Hogan PE, Kotchen JM, Smoller JW, Denburg NL, Manson JE, Tummala A, Mysiw WJ, Ockene JK, Woods NF, Espeland MA, Wassertheil-Smoller S.

Int Psychogeriatr. 2012 Aug;24(8):1252-64. doi: 10.1017/S1041610211002778. Epub 2012 Feb 3.

Citalopram for agitation in Alzheimer's disease: design and methods

Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, Pelton G, Frangakis C, Rabins PV, Munro CA, Meinert CL, Devanand DP, Yesavage J, Mintzer JE, Schneider LS, Pollock BG, Lyketsos CG; CitAD Research Group.

Alzheimers Dement. 2012;8(2):121-30. doi: 10.1016/j.jalz.2011.01.007. Epub 2012 Feb 1.

The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout

Chang KA, Kim HJ, Suh YH.

Neurodegener Dis. 2012;10(1-4):27-9. doi: 10.1159/000333781. Epub 2012 Feb 1.

Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease

Chételat G, Villemagne VL, Pike KE, Ellis KA, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of Ageing Research Group.

Neurodegener Dis. 2012;10(1-4):141-4. doi: 10.1159/000334295. Epub 2012 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias